Core Viewpoint - Southbound funds increased their holdings in Baize Medical (02609.HK) by 10,200 shares on December 9, indicating a potential positive sentiment towards the company [1] Group 1: Southbound Fund Activity - Over the past 5 trading days, there was a net reduction of 382,800 shares, with southbound funds reducing their holdings on one day [1] - In the last 20 trading days, there were 10 days of net reductions totaling 2,009,400 shares [1] - Currently, southbound funds hold 62,471,400 shares of Baize Medical, representing 4.73% of the company's total issued ordinary shares [1] Group 2: Company Overview - Baize Medical Group primarily engages in investment and provision of medical-related services, focusing on oncology [1] - The company offers comprehensive oncology medical services, including screening, diagnosis, treatment, and rehabilitation [1] - Its business operations include hospital services, hospital management, supply of pharmaceuticals, medical devices, consumables, and other related services [1] - The company also conducts early cancer screening, tumor vaccination, and health management services for potential healthy populations, primarily in the Chinese market [1]
佰泽医疗（02609.HK）：12月9日南向资金增持1.02万股